Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Bullboard Posts
Comment by Tunee70on Jun 18, 2015 9:17pm
252 Views
Post# 23846847

RE:RE:Now Thursday has to make them think twice

RE:RE:Now Thursday has to make them think twice Currently the market cap is $348 million with 30 million in run rate Ebitda would give an 11.5 x ebitda multiple with no allowance for growth, but Sleep co is growing organically at well over 50% before cross-selling so that multiple will actually end up much lower.

50 million in Loi's expected to close with a minimum 10 million in Ebitda would take that multiple down to 8.7, again with no allowance for growth.

We may miss on an Loi occasionally but they have a pipeline full of replacements and a big cash hord to execute.

i think conservatively we are looking at 48-50 million in ebitda run rate with what is closed, whats in Loi's and a small amount of cross-selling which puts us around 7 x ebitda 
Bullboard Posts